The following is a summary of “Longitudinal Links between Changes in Body Composition and Liver Disease Severity in Children ...

The FDA has updated the prescribing information for Veozah (fezolinetant) to include a warning regarding the risk of serious liver injury.

The FDA has approved Kisqali (ribociclib) in adults with HR-positive, HER2-negative stage II and III early breast cancer.

A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with ...

Findings from the NATALEE trial show that the combination of Kisqali and an aromatase inhibitor resulted in disease-free ...

bVictorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia cBarcelona Institute for Global 3 ...

Additionally, AEs can include an increase in alanine aminotransferase, aspartate aminotransferase, infections, creatinine, headache, nausea, and fatigue. Patients with advanced or metastatic breast ...

Study found that higher soft drink consumption is associated with an increased risk of nonalcoholic fatty liver disease, ...

Cannabinoids used for medical purposes in children and adolescents come with a risk of adverse events, a systematic review ...